Dow Chemical, Fed Decision, Oprah
Bloomberg Intelligence
00:00
Oprah's Impact on Weight Loss Drugs
The chapter delves into Oprah's involvement with promoting GLP-1 drugs for weight loss, despite not disclosing the specific one she uses. It discusses her association with these medications and the evolving dynamics of the weight loss industry, including the intersection with plastic surgery trends. The segment also highlights the challenges faced by pharmaceutical companies in meeting the rising demand for weight loss drugs and the potential risks to Oprah's reputation.
Transcript
Play full episode
